IR@PKUHSC  > 北京大学口腔医学院
学科主题口腔医学
Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells
Zhang, Shan1,2; Wang, Xiao-Ling3,4; Gan, Ye-Hua1,2; Li, Sheng-Lin1,2
关键词apoptosis cell growth inhibition mitogen-activated protein kinases salivary adenoid cystic carcinoma statin
刊名ANTI-CANCER DRUGS
2010-08-01
DOI10.1097/CAD.0b013e32833c4b3b
21期:7页:678-686
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Pharmacology & Pharmacy
研究领域[WOS]Oncology ; Pharmacology & Pharmacy
关键词[WOS]SMOOTH-MUSCLE-CELLS ; COENZYME-A REDUCTASE ; BREAST-CANCER CELLS ; HMG-COA REDUCTASE ; MAP KINASE ; PROTEIN-KINASES ; GLIOMA-CELLS ; SIMVASTATIN ; LOVASTATIN ; INHIBITION
英文摘要

Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, originally developed for lowering cholesterol. Statins also have pleiotropic effects, independent of cholesterol-lowering effects, including induction of apoptosis in various cell lines. However, the mechanism underlying statin-induced apoptosis is still not fully understood. This study aims to explore the proapoptotic effects and underlying mechanisms of statins on human salivary adenoid cystic carcinoma (SACC). Exposure of SACC cells to mevastatin resulted in cell growth inhibition and apoptosis in a dose-dependent manner, accompanied by the release of cytochrome c and cleavage of caspase-3. A remarkable decrease in phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and increase in phosphorylation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated kinase were observed. Furthermore, the JNK-specific inhibitor SP600125, but not the p38-specific inhibitor SB203580, abolished mevastatin-induced cell growth inhibition and apoptosis in SACC cells. This was supported by results in which the JNK inhibitor efficiently blocked mevastatin-induced JNK phosphorylation, but not p38 phosphorylation, and further decreased mevastatin-induced phosphorylation of ERK1/2. Taken together, the results suggest that the JNK pathway was required for mevastatin-induced cell growth inhibition and apoptosis in SACC cells. Statins could be potential anticancer agents for SACC chemotherapy. Anti-Cancer Drugs 21:678-686 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

语种英语
WOS记录号WOS:000279649800003
项目编号2006-331
资助机构Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63572
专题北京大学口腔医学院
北京大学口腔医学院_中心实验室
作者单位1.Peking Univ, Cent Lab, Sch Stomatol, Beijing 100081, Peoples R China
2.Peking Univ, Cent Lab, Hosp Stomatol, Beijing 100081, Peoples R China
3.Peking Univ, Dept Prevent Dent, Sch Stomatol, Beijing 100081, Peoples R China
4.Peking Univ, Dept Prevent Dent, Hosp Stomatol, Beijing 100081, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Shan,Wang, Xiao-Ling,Gan, Ye-Hua,et al. Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells[J]. ANTI-CANCER DRUGS,2010,21(7):678-686.
APA Zhang, Shan,Wang, Xiao-Ling,Gan, Ye-Hua,&Li, Sheng-Lin.(2010).Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.ANTI-CANCER DRUGS,21(7),678-686.
MLA Zhang, Shan,et al."Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells".ANTI-CANCER DRUGS 21.7(2010):678-686.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Shan]的文章
[Wang, Xiao-Ling]的文章
[Gan, Ye-Hua]的文章
百度学术
百度学术中相似的文章
[Zhang, Shan]的文章
[Wang, Xiao-Ling]的文章
[Gan, Ye-Hua]的文章
必应学术
必应学术中相似的文章
[Zhang, Shan]的文章
[Wang, Xiao-Ling]的文章
[Gan, Ye-Hua]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。